+65.3%
GSK vs BBAI
+24.0%
+41.3%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBAI | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | -7.7% | +8.3% | +0.7% |
| 7D | +1.1% | -14.0% | +15.1% | +1.4% |
| 30D | +6.3% | -12.4% | +18.7% | +6.5% |
| 3M | +1.8% | -42.8% | +44.6% | +2.7% |
| 6M | +1.7% | -54.6% | +56.3% | +2.8% |
| YTD | +6.5% | -64.6% | +71.2% | +8.1% |
| 1Y | +9.5% | -69.9% | +79.4% | +11.3% |
| 3Y | +65.3% | +7.3% | +58.0% | +59.1% |
| All | +65.3% | +24.0% | +41.3% | +59.1% |
Cumulative growth
Daily Returns
Daily percentage return beside BBAI.
Daily Out/Under-Performance
Portfolio return minus BBAI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBAI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBAI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling